Tokyo Tape
Sign in
← Hokuyaku Takeyama Holdings

Quarterly report · Q3

3055.TEDINET S100SUQB
Period2023-04-01 → 2023-12-31
Filed2024-02-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥209.2bn2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥262.6bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥199.1bn2022-04-01 → 2022-12-31Cons.Net sales
Operating income¥2.4bn2023-04-01 → 2023-12-31Cons.Operating income
Operating income¥2.7bn2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income¥2.9bn2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥3.9bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥3.2bn2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥2.9bn2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥3.6bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥1.8bn2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.7bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥2.4bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥1.8bn2023-04-01 → 2023-12-31Cons.Profit loss
Net income¥2.4bn2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥151.9bnat 2023-12-31Cons.Assets
Total assets¥137.9bnat 2023-03-31Cons.Assets
Total assets¥146.6bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥92.6bnat 2023-12-31Cons.Liabilities
Total liabilities¥80.5bnat 2023-03-31Cons.Liabilities
Net assets / equity¥59.3bnat 2023-12-31Cons.Net assets
Net assets / equity¥57.4bnat 2023-03-31Cons.Net assets
Net assets / equity¥57.6bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥19.5bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥18.0bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥19.5bnat 2023-12-31Cons.Cash and cash equivalents
Cash & equivalents¥18.0bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥21.4bnat 2022-12-31Cons.Cash and cash equivalents
Cash & equivalents¥21.1bnat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow¥4.5bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in operating activities
Operating cash flow−¥828m2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥2.0bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥2.2bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥1.4bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥856m2022-04-01 → 2022-12-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥865m2023-04-01 → 2023-12-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥835m2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥808m2022-04-01 → 2022-12-31Cons.Net cash provided by used in financing activities
EPS (basic)¥82.92023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥49.92023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥123.412022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥109.942022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥46.722022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio39.0%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio41.6%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio39.3%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 56
SegmentItemPeriodValue
Otherother segmentsrevenue2023-04-01 → 2023-12-31¥1.6bn
Otherother segmentsrevenue external2023-04-01 → 2023-12-31¥44m
Otherother segmentsrevenue intersegment2023-04-01 → 2023-12-31¥1.5bn
Otherother segmentssegment profit2023-04-01 → 2023-12-31¥516m
jpcrp040300-q3r_E03003-000Dispensing Industryreportable segmentrevenue2023-04-01 → 2023-12-31¥10.1bn
jpcrp040300-q3r_E03003-000Dispensing Industryreportable segmentrevenue external2023-04-01 → 2023-12-31¥10.1bn
jpcrp040300-q3r_E03003-000Dispensing Industryreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥9m
jpcrp040300-q3r_E03003-000Dispensing Industryreportable segmentsegment profit2023-04-01 → 2023-12-31¥113m
jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segmentrevenue2023-04-01 → 2023-12-31¥1.2bn
jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segmentrevenue external2023-04-01 → 2023-12-31¥369m
jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥794m
jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segmentsegment profit2023-04-01 → 2023-12-31¥48m
jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue2023-04-01 → 2023-12-31¥49.0bn
jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue external2023-04-01 → 2023-12-31¥48.6bn
jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥401m
jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segmentsegment profit2023-04-01 → 2023-12-31¥911m
jpcrp040300-q3r_E03003-000Nursing Industryreportable segmentrevenue2023-04-01 → 2023-12-31¥3.1bn
jpcrp040300-q3r_E03003-000Nursing Industryreportable segmentrevenue external2023-04-01 → 2023-12-31¥3.1bn
jpcrp040300-q3r_E03003-000Nursing Industryreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥3m
jpcrp040300-q3r_E03003-000Nursing Industryreportable segmentsegment profit2023-04-01 → 2023-12-31¥217m
jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue2023-04-01 → 2023-12-31¥153.6bn
jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue external2023-04-01 → 2023-12-31¥146.9bn
jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥6.7bn
jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segmentsegment profit2023-04-01 → 2023-12-31¥1.3bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-12-31¥218.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-12-31¥209.2bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-12-31¥9.4bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-12-31¥3.1bn
Otherother segmentsrevenue2022-04-01 → 2022-12-31¥1.9bn
Otherother segmentsrevenue external2022-04-01 → 2022-12-31¥46m
Otherother segmentsrevenue intersegment2022-04-01 → 2022-12-31¥1.8bn
Otherother segmentssegment profit2022-04-01 → 2022-12-31¥819m
jpcrp040300-q3r_E03003-000Dispensing Industryreportable segmentrevenue2022-04-01 → 2022-12-31¥10.2bn
jpcrp040300-q3r_E03003-000Dispensing Industryreportable segmentrevenue external2022-04-01 → 2022-12-31¥10.2bn
jpcrp040300-q3r_E03003-000Dispensing Industryreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥9m
jpcrp040300-q3r_E03003-000Dispensing Industryreportable segmentsegment profit2022-04-01 → 2022-12-31−¥14m
jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segmentrevenue2022-04-01 → 2022-12-31¥1.2bn
jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segmentrevenue external2022-04-01 → 2022-12-31¥362m
jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥825m
jpcrp040300-q3r_E03003-000Information And Communication Technology Industryreportable segmentsegment profit2022-04-01 → 2022-12-31¥25m
jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue2022-04-01 → 2022-12-31¥49.2bn
jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue external2022-04-01 → 2022-12-31¥48.9bn
jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥379m
jpcrp040300-q3r_E03003-000Medical Equipment Wholesale Industryreportable segmentsegment profit2022-04-01 → 2022-12-31¥1.1bn
jpcrp040300-q3r_E03003-000Nursing Industryreportable segmentrevenue2022-04-01 → 2022-12-31¥3.0bn
jpcrp040300-q3r_E03003-000Nursing Industryreportable segmentrevenue external2022-04-01 → 2022-12-31¥3.0bn
jpcrp040300-q3r_E03003-000Nursing Industryreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥2m
jpcrp040300-q3r_E03003-000Nursing Industryreportable segmentsegment profit2022-04-01 → 2022-12-31¥295m
jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue2022-04-01 → 2022-12-31¥143.5bn
jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue external2022-04-01 → 2022-12-31¥136.6bn
jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥6.9bn
jpcrp040300-q3r_E03003-000Wholesaler Of Drugs Industryreportable segmentsegment profit2022-04-01 → 2022-12-31¥1.6bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥209.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥199.1bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥9.9bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥3.8bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 517
ItemContextValueUnit
Income before income taxesPrior1YTDDuration3616000000JPY
Income before income taxesCurrentYTDDuration2934000000JPY
Income taxes currentPrior1YTDDuration923000000JPY
Income taxes currentCurrentYTDDuration826000000JPY
Income taxes deferredPrior1YTDDuration254000000JPY
Income taxes deferredCurrentYTDDuration301000000JPY
Income taxesPrior1YTDDuration1178000000JPY
Income taxesCurrentYTDDuration1127000000JPY
Profit lossPrior1YTDDuration2438000000JPY
Profit lossCurrentYTDDuration1806000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration1000000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration1000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration2436000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration1805000000JPY
Profit lossPrior1YTDDuration2438000000JPY
Profit lossCurrentYTDDuration1806000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration328000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration847000000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration14000000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration14000000JPY
Other comprehensive incomePrior1YTDDuration343000000JPY
Other comprehensive incomeCurrentYTDDuration862000000JPY
Comprehensive incomePrior1YTDDuration2781000000JPY
Comprehensive incomeCurrentYTDDuration2669000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration2779000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration2668000000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration1000000JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration1000000JPY
Income before income taxesPrior1YTDDuration3616000000JPY
Income before income taxesCurrentYTDDuration2934000000JPY
Depreciation and amortization ope cfPrior1YTDDuration804000000JPY
Depreciation and amortization ope cfCurrentYTDDuration797000000JPY
Amortization of goodwill ope cfPrior1YTDDuration83000000JPY
Amortization of goodwill ope cfCurrentYTDDuration81000000JPY
Increase decrease in allowance for doubtful accounts ope cfPrior1YTDDuration-17000000JPY
Increase decrease in allowance for doubtful accounts ope cfCurrentYTDDuration-10000000JPY
Interest and dividends income ope cfPrior1YTDDuration-276000000JPY
Interest and dividends income ope cfCurrentYTDDuration-301000000JPY
Interest expenses ope cfPrior1YTDDuration0JPY
Interest expenses ope cfCurrentYTDDuration0JPY
Equity in earnings losses of affiliates ope cfPrior1YTDDuration-88000000JPY
Equity in earnings losses of affiliates ope cfCurrentYTDDuration-95000000JPY
Loss gain on sales of noncurrent assets ope cfPrior1YTDDuration0JPY
Loss gain on sales of noncurrent assets ope cfCurrentYTDDuration0JPY
Loss on retirement of noncurrent assets ope cfPrior1YTDDuration1000000JPY
Loss on retirement of noncurrent assets ope cfCurrentYTDDuration1000000JPY
Loss gain on sales of investment securities ope cfPrior1YTDDuration-385000000JPY
Loss gain on sales of investment securities ope cfCurrentYTDDuration-18000000JPY
Loss gain on valuation of investment securities ope cfPrior1YTDDuration－JPY
Loss gain on valuation of investment securities ope cfCurrentYTDDuration122000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass